摘要结核病是严重危害人民身体健康的慢性传染病，需要多种抗结核药物联合使用，不间断用药半年以上，在治疗过程中病人可能出现各种不同程度的不良反应（adverse drug reactions。ADRs），而影响结核病的防治。要全面了解并注意观察结核病治疗中可能出现的不良反应，及时处理，使病人能够坚持完成治疗，避免发生严重的不良反应。
8Pan X, Wang L, Grtindemann D, et al. Interaction of ethambutol with human organic cation transporters of the SLC22 family indicates potential for drug-drug interactions during antituberculosis therapy[J].Antimicrob Agents Chemother, 2013, 57(10):5053.
9Steele MA, Burk RF, DesPrez RM.Toxic hepatitis with isoniazid and rifampin. A meta-analysis[J]. Chest, 1991, 99(2):465.
10Gupta VH, Amarapurkar DN, Singh M, et al. Association of N-acetyltransferase 2 and cytochrome P450 2El gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India[J].J Gastroenterol Hepatol, 2013, 28(8):1368.
